232 related articles for article (PubMed ID: 9698051)
21. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
23. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
[TBL] [Abstract][Full Text] [Related]
24. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
25. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
De Souza EB
Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
[TBL] [Abstract][Full Text] [Related]
26. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
27. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
Wong AO; Chang JP; Peter RE
Endocrinology; 1992 Mar; 130(3):1201-10. PubMed ID: 1347006
[TBL] [Abstract][Full Text] [Related]
28. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
Zhao Y; Kerscher N; Eysel U; Funke K
J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
[TBL] [Abstract][Full Text] [Related]
29. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Woolf PD
Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
[TBL] [Abstract][Full Text] [Related]
30. Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary.
Recouvreux MV; Guida MC; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2011 Jul; 152(7):2722-30. PubMed ID: 21521749
[TBL] [Abstract][Full Text] [Related]
31. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
Braghiroli L; Ponzianelli A; Mazzanti G
Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
[TBL] [Abstract][Full Text] [Related]
34. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
35. One minute of bromocriptine irreversibly inhibits prolactin release for hours.
Cronin MJ; Evans WS; Thorner MO
Eur J Pharmacol; 1984 Mar; 99(1):85-90. PubMed ID: 6723793
[TBL] [Abstract][Full Text] [Related]
36. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats.
Gao X; Zhang Y; Wu G
Eur J Pharmacol; 2001 Apr; 418(1-2):73-7. PubMed ID: 11334867
[TBL] [Abstract][Full Text] [Related]
38. LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.
Watts VJ; Lawler CP; Fox DR; Neve KA; Nichols DE; Mailman RB
Psychopharmacology (Berl); 1995 Apr; 118(4):401-9. PubMed ID: 7568626
[TBL] [Abstract][Full Text] [Related]
39. Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.
Ren SG; Kim S; Taylor J; Dong J; Moreau JP; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Nov; 88(11):5414-21. PubMed ID: 14602782
[TBL] [Abstract][Full Text] [Related]
40. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Dutt A; Juneja HS
Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
